Requires covered entities to report to the Department of Health on 340B drug discounts and patient benefits.

The bill mandates that covered entities report to the Department of Health on various aspects of their 340B drug discount programs. These reports must include the total number of prescriptions filled with 340B drugs, the percentage of prescriptions filled with these drugs, and the percentage of patients served by a sliding fee scale for low-income patients. Additionally, the reports should detail the total operating costs and itemized costs for implementing direct pass-through of 340B profits to patients.

Requires covered entities to report to the Department of Health on 340B drug discounts and patient benefits.

The bill mandates that covered entities report to the Department of Health on various aspects of their 340B drug discount programs. These reports must include the total number of prescriptions filled with 340B drugs, the percentage of prescriptions filled with these drugs, and the percentage of patients served by a sliding fee scale for low-income patients. Additionally, the reports should detail the total operating costs and itemized costs for implementing direct pass-through of 340B profits to patients.